These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19375923)

  • 1. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy for newly diagnosed glioblastoma: a pilot study in Tsukuba.
    Yamamoto T; Nakai K; Tsurubuchi T; Matsuda M; Shirakawa M; Zaboronok A; Endo K; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S25-6. PubMed ID: 19375927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma.
    Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2011 Dec; 69(12):1823-5. PubMed ID: 21684170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy combined with fractionated photon irradiation for glioblastoma: a recursive partitioning analysis of BNCT patients.
    Nakai K; Yamamoto T; Aiyama H; Takada T; Yoshida F; Kageji T; Kumada H; Isobe T; Endo K; Matsuda M; Tsurubuchi T; Shibata Y; Takano S; Mizumoto M; Tsuboi K; Matsumura A
    Appl Radiat Isot; 2011 Dec; 69(12):1790-2. PubMed ID: 21565517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
    Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron neutron capture therapy for newly diagnosed glioblastoma.
    Yamamoto T; Nakai K; Kageji T; Kumada H; Endo K; Matsuda M; Shibata Y; Matsumura A
    Radiother Oncol; 2009 Apr; 91(1):80-4. PubMed ID: 19285355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neutron capture therapy in the treatment of glioblastoma multiforme. Initial experience in the Czech Republic].
    Honová H; Safanda M; Petruzelka L; Burian J; Marek M; Rejchrt J; Sus F; Tovarys F; Dbalý V; Honzátko J; Tomandl I; Mares V
    Cas Lek Cesk; 2004; 143(1):44-7. PubMed ID: 15061119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A treatment planning study on glioblastoma with different techniques using boron neutron capture therapy, 3-dimensional conformal radiotherapy, and intensity modulated radiotherapy.
    Jung SH; Yoon SM; Park SH; Choi IS; Kim JK; Choi EK; Ahn SD; Lee SW; Song SY; Kim JH
    Appl Radiat Isot; 2009; 67(7-8):1180-4. PubMed ID: 19321353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current clinical results of the Tsukuba BNCT trial.
    Yamamoto T; Matsumura A; Nakai K; Shibata Y; Endo K; Sakurai F; Kishi T; Kumada H; Yamamoto K; Torii Y
    Appl Radiat Isot; 2004 Nov; 61(5):1089-93. PubMed ID: 15308197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.
    Matsuda M; Yamamoto T; Ishikawa E; Nakai K; Zaboronok A; Takano S; Matsumura A
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S54-60. PubMed ID: 21427185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma.
    Kageji T; Nagahiro S; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2004 Nov; 61(5):1063-7. PubMed ID: 15308193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
    Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.